SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2004
DOBI MEDICAL INTERNATIONAL, INC.
-------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-32523 98-0222710
---------------------------- -------------- --------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
1200 MacArthur Blvd.
Mahwah, New Jersey 07430
---------------------- ------------
(Address of principal (Zip Code)
executive offices)
Registrant's telephone number, including area code: (201) 760-6464
CURRENT REPORT ON FORM 8-K
DOBI MEDICAL INTERNATIONAL, INC.
April 29, 2004
Item 5. Other Events and Required FD Disclosure
As previously reported, DOBI Medical International, Inc. had agreed with
investors in its December 9, 2003 private placement to file on or around April
1, 2004 a registration statement with the Securities and Exchange Commission
permitting the resale of their shares. In accordance with waivers received from
holders of 96% of the securities sold in that private placement, DOBI Medical
has extended the date by which it will file its "resale" registration statement
to on or around June 30, 2004. Other than with respect to 229,400 shares of
common stock (approximately 4% of the total securities sold), no penalties will
accrue as a result of the waivers and extensions from the private placement
investors.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits.
None.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DOBI MEDICAL INTERNATIONAL, INC.
Dated: April 29, 2004 By: /s/ Phillip C. Thomas
--------------------------------
Phillip C. Thomas
Chief Executive Officer